EXCLUSIVE OFFER
15% OFF
when you order 10 or more vials
Free shipping included 🚚
Discount applied automatically at checkout
MAZMolecular Weight~4,200 Da
Purity≥99%
CategoryGLP-1 Agonists
Status
In Stock
TESTED
COLD-CHAIN
CANADA
GLP-1 AGONISTS
Mazdutide
A dual GLP-1/glucagon receptor agonist in advanced clinical trials for obesity and type 2 diabetes research.
PRICE PER VIALCA$200.00CAD
10+ VIALSCA$1700.0015% BULK DISCOUNT
10mg per vial · mg/vial
Mazdutide (IBI362/LY3305677) is a novel OXM-based dual GLP-1 and glucagon receptor agonist developed by Innovent Biologics and Eli Lilly. Phase 3 GLORY clinical trials demonstrated significant weight reduction and metabolic improvements. The glucagon receptor activity adds hepatic lipid metabolism and energy expenditure components beyond pure GLP-1 agonism.
Key Research Applications
Dual GLP-1/GCG agonist
Advanced obesity research
Hepatic lipid metabolism
Energy expenditure boost
Phase 3 clinical data
Research Dosage Calculator
4 weeks
1 wk24 wks
CALCULATED REQUIREMENTS
DOSE PER INJECTION0.5 mg
TOTAL INJECTIONS4
TOTAL mg NEEDED2 mg
VIALS REQUIRED1 vial
RECONSTITUTION GUIDE (per 10mg vial + 1mL BAC water)Draw 0.050 mL per injection
ESTIMATED COST~$NaN USD
For research use only. Dosage calculations are estimates based on published research protocols. Consult primary literature for your specific research application.